StonvexLoading…
StonvexStonvexStonvexCore line items from GNLN's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
Quarterly filings sourced directly from SEC EDGAR. Real-time earnings actuals are in the Earnings panel above.
| Metric | Annual 2025 2025-12-31 | Annual 2024 2024-12-31 | Annual 2023 2023-12-31 | Annual 2022 2022-12-31 |
|---|---|---|---|---|
Revenue | $4.36M | $13.28M | $65.37M | $137.09M |
Operating Income | $-54.25M | $-11.81M | $-26.08M | $-184.10M |
Net Income | $-85.58M | $-17.64M | $-32.17M | $-169.51M |
EPS (Diluted) | $-11.42 | $-14.56 | $-8.16 | $-22.51 |
Total Assets | $74.93M | $28.63M | $38.09M | $89.69M |
Total Liabilities | $7.21M | $22.35M | $27.10M | $50.69M |
Cash & Equivalents | $32.51M | $899.00K | $463.00K | $6.46M |
Free Cash Flow OCF − CapEx | $-16.36M | $-6.99M | $-2.80M | $-29.21M |
Shares Outstanding | 7.49M | 1.21M | 363.00K | 753.00K |